Stephan K. Metzelder
Marburg An Der Lahn, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.
Journal: British journal of haematology
Published: March 04, 2026
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).
Journal: Leukemia
Published: October 28, 2025
Malnutrition in Cancer Patients - An Investigation of Malnutrition and Professional Intervention by Healthcare Professionals in Oncology.
Journal: In vivo (Athens, Greece)
Published: June 06, 2025
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study.
Journal: British journal of haematology
Published: June 28, 2024
Reply to S. Fuji.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 23, 2021
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 17, 2020
Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantation.
Journal: Leukemia & lymphoma
Published: January 16, 2019
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.
Journal: Nature medicine
Published: April 11, 2018
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.
Journal: Leukemia
Published: January 31, 2018
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial).
Journal: Leukemia
Published: July 29, 2017
Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 25, 2017
Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia.
Journal: Leukemia research
Published: February 26, 2017
Last Updated: 09/26/2026